Peripal AG is a privately funded start-up from the ETH Z├╝rich and the medtech industryfocusing on patient aids for home care patients in the field of dialysis.

The vision of Peripal is to allow patients to be treated at home and to contribute to lower healthcare costs. Its mission is to develop and market support devices that enable more patients worldwide to be treated in their homes and to be treated more safely.

The team offers a unique combination of product development capabilities, a longstanding experience in the dialysis market, a successful track record of strategy, sales, and marketing positions, and excellent contacts and network in the nephrology community.

Peripal AG has secured initial financing and has closed a Series A financing round in 2016.